On the basis of the record  developed in the subject five-year review, the United States International Trade Commission (Commission) determines, pursuant to section 751(c) of the Tariff Act of 1930 (19 U.S.C. 1675(c)), that revocation of the antidumping duty order on glycine from China would be likely to lead to continuation or recurrence of material injury to an industry in the United States within a reasonably foreseeable time.
The Commission instituted this review on October 7, 2010 (75 FR 62141) and determined on January 4, 2011 that it would conduct a full review (76 FR 8771, February 15, 2011). Notice of the scheduling of the Commission's review and of a public hearing to be held in connection therewith was given by posting copies of the notice in the Office of the Secretary, U.S. International Trade Commission, Washington, DC, and by publishing the notice in the Federal Register on February 15, 2011 (76 FR 8771). The hearing was held in Washington, DC, on June 30, 2011, and all persons who requested the opportunity were permitted to appear in person or by counsel.
The Commission transmitted its determination in this review to the Secretary of Commerce on August 30, 2011. The views of the Commission are contained in USITC Publication 4255 (August 2011), entitled Glycine from China: Investigation No. 731-TA-718 (Third Review).Start Signature
By order of the Commission.
Issued: August 30, 2011.
James R. Holbein,
Secretary to the Commission.
[FR Doc. 2011-22638 Filed 9-2-11; 8:45 am]